Clinical Trials

NCT07087054 | RECRUITING | PHASE3
141 participants

Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-04
Start Date:
2025-11-19
Completion:
2027-08-31
Conditions
  • Carcinoid Syndrome
  • Carcinoid
  • Carcinoid Tumor
  • Carcinoid Tumor of Ileum
  • Carcinoid Tumor of Cecum
  • Carcinoid Tumor of Liver
  • Carcinoid Tumor of Pancreas
  • Carcinoid Syndrome Diarrhea
  • Carcinoid Intestine Tumor
Interventions
  • DRUG
No Results Yet
NCT07016230 | ACTIVE_NOT_RECRUITING | PHASE2
40 participants

Study Investigating Tarlatamab (AMG 757) in Patients With Metastatic/Locally Advanced Small-Cell Lung Cancer (SCLC) and Other Poorly Differentiated Neuroendocrine Carcinomas (NECs), With Biomarker Analysis to Characterize Response/Resistance (UNLOCK TARLATAMAB)

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-04
Start Date:
2025-07-02
Completion:
2026-10-18
Conditions
  • Metastatic/Locally Advanced Small-Cell Lung Cancer
  • Metastatic/Locally Advanced Poorly Differentiated NEC
  • Metastatic/Locally Advanced High-grade MTC
Interventions
  • DRUG
No Results Yet
NCT06994520 | ENROLLING_BY_INVITATION | PHASE2
60 participants

Efficacy of Topical Cannabidiol for Eczema

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-04
Start Date:
2025-05-01
Completion:
2027-08-01
Conditions
  • Chronic Pruritus
  • Eczema
  • Nummular Eczema
  • Atopic Dermatitis
  • Prurigo Nodularis
Interventions
  • OTHER
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page